Clinical Trial

Intravascular Lithotripsy in High Risk Calcified Iliac Anatomy for Transfemoral TAVR

Study acronym: ILIT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 13, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
To assess the efficacy and safety of Intravascular Lithotripsy (IVL) in subjects undergoing transfemoral TAVR in patients with severe iliac disease, prohibitive for transfemoral TAVR in patients with severe symptomatic aortic stenosis, otherwise considered for alternative access TAVR. (e.g. trans-carotid)
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-05-08.
Trial Details
NCT Number NCT05862558
Lead Sponsor Baylor Research Institute
Collaborators: Shockwave Medical, Inc.
Conditions Iliac Disease, Aortic Valve Stenosis
Enrollment 50 participants
Start Date 2023-03-30
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-13